What is Buparlisib used for?

Buparlisib is being studied for its ability to treat several types of cancer, such as breast cancer, melanoma, and certain leukemias.

How does Buparlisib work?

Buparlisib works by blocking PI3-kinase class I, which is a pathway involved in cell growth.

Is Buparlisib approved for cancer treatment?

Buparlisib is currently in clinical research phases (up to Phase 3) and is not yet an FDA-approved standard medication for these uses.

What kind of molecule is Buparlisib?

Buparlisib is classified as a small molecule.

Can Buparlisib treat prostate cancer?

Research is looking into whether Buparlisib can be used for prostate cancer.

Is Buparlisib taken by mouth?

The provided information does not specify if Buparlisib is an oral or injectable medication.

Buparlisib | CAS 944396-07-0 | CWHUFRVAEUJCEF

Loading compound...

PI3-kinase inhibitor

Buparlisib is a small molecule drug currently being studied in clinical trials. It works as a PI3-kinase class I inhibitor, which means it is designed to interfere with specific signaling pathways in cells. It is being investigated for its potential to treat various types of cancer, including breast cancer and certain types of leukemia.

How it worksBuparlisib works by inhibiting PI3-kinase class I, a protein pathway that helps cells grow and survive.

Used for

Breast cancerHead and neck cancerMelanomaGlioblastomaChronic lymphocytic leukemiaMantle cell lymphomaNon-small cell lung carcinomaThyroid cancerCervical cancerEsophageal cancerProstate cancerEndometrial cancer

Conditions

Breast cancerHead and neck cancerMelanomaGlioblastomaLeukemiaLymphomaLung cancerThyroid cancerCervical cancerEsophageal cancerProstate cancerEndometrial cancer

Class

PI3K InhibitorSmall MoleculeAntineoplasticPI3-kinase inhibitorEndocrine systemImmune systemRespiratory systemReproductive system

How to take

Buparlisib is currently in clinical development stages (Max Phase 3) and is not yet widely available as an approved standard treatment for all listed conditions. Always follow the specific instructions provided by a clinical trial investigator or healthcare professional.

Talk to your doctor

Questions to ask

·Is Buparlisib part of a clinical trial I can join?
·How does Buparlisib target my specific type of cancer?
·What are the potential risks of PI3-kinase inhibitors?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.

How to take

Talk to your doctor

Frequently asked questions (6)